Cromwell Holdings’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96K Hold
259
– – 0.04% 353
2026
Q2
$93K Buy
259
+11
+4% +$3.36K 0.04% 370
2026
Q1
$62.2K Hold
248
– – 0.04% 434
2025
Q4
$68.2K Hold
248
– – 0.04% 403
2025
Q3
$65.1K Buy
248
+28
+13% +$6.8K 0.03% 425
2025
Q2
$48.1K Buy
220
+188
+588% +$40.2K 0.03% 471
2025
Q1
$7.16K Sell
32
-199
-86% -$54.8K ﹤0.01% 599
2024
Q4
$75.7K Buy
231
+83
+56% +$26.1K 0.04% 351
2024
Q3
$44.4K Sell
148
-60
-29% -$18.4K 0.03% 483
2024
Q2
$68.5K Buy
+208
New +$73.5K 0.04% 362

Other funds holding WST

Cromwell Holdings's WST Position: Q3 2026 in Review

Cromwell Holdings held its West Pharmaceutical (WST) position steady in Q3 2026 at 259 shares worth $96K. The position accounts for 0.04% of the portfolio, ranked #353.

Cromwell Holdings first reported a position in WST in Q2 2024 and has held it in 10 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Cromwell Holdings held 259 shares of West Pharmaceutical worth $96K as of Q3 2026.
  • Cromwell Holdings left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.04% of Cromwell Holdings's portfolio in Q3 2026, its #353 holding.
  • Cromwell Holdings first reported a position in West Pharmaceutical in Q2 2024 and has held it in 10 quarters since.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.